• Education
  • Get the app
  • Country
    singapore
    hong kong
    malaysia
    indonesia
    thailand
    philippines
    vietnam
    india

    australia
    korea
    new zealand
The MIMS logo.
  • Home
  • Find Drugs
  • Pill Identifier
  • Find Drug Company
  • Diseases
  • Medical News & Updates
The MIMS logo.
Home Find Drugs Pill Identifier Find Drug Company Diseases Medical News & Updates
Other Services
MIMS Education Download App
Country
  • a globesingapore
  • a globehong kong
  • a globemalaysia
  • a globeindonesia
  • a globephilippines
  • a globevietnam
  • a globeindia
  • a globeaustralia
  • a globekorea
  • a globenew zealand
The MIMS logo.
Molecular structure pattern
  1. Home icon
  2. Diseases
  3. Diarrhea in Adults - Infectious
    • Diseases
    • Diarrhea in Adults - Infectious
  4. Follow Up

Diarrhea in Adults - Infectious Follow Up

Last updated: 06 August 2026
Reviewed by
PAGINATION TESTMIMS Gastroenterology Honorary Editorial Advisory Board
Follow Up
Monitoring
OverviewHistory and Physical ExaminationDiagnosisManagement
IntroductionEpidemiologyEtiologyPathophysiologyRisk FactorsClassification
Clinical PresentationHistoryPhysical ExaminationScreening
Laboratory Tests and AncillariesImaging
Differential Diagnosis
EvaluationPrinciples of TherapyPharmacological therapyNonpharmacologicalPrevention
Monitoring
AminoglycosideAntibacterial CombinationAntidiarrhealsCephalosporinElectrolytes*MacrolideOther AntibioticsPenicillinsQuinolonesTetracyclinesVaccines, Antisera & ImmunologicalsDisclaimerRelated MIMS Drugs
OverviewHistory and Physical ExaminationDiagnosisManagement
IntroductionEpidemiologyEtiologyPathophysiologyRisk FactorsClassification
Clinical PresentationHistoryPhysical ExaminationScreening
Laboratory Tests and AncillariesImaging
Differential Diagnosis
EvaluationPrinciples of TherapyPharmacological therapyNonpharmacologicalPrevention
Monitoring
AminoglycosideAntibacterial CombinationAntidiarrhealsCephalosporinElectrolytes*MacrolideOther AntibioticsPenicillinsQuinolonesTetracyclinesVaccines, Antisera & ImmunologicalsDisclaimerRelated MIMS Drugs

Monitoring

Follow-up testing is not recommended in most patients after resolution of diarrhea. Clinical and laboratory reevaluation may be indicated in patients who did not respond to an initial course of therapy and should include consideration of non-infectious conditions. Non-infectious conditions (eg IBD and IBS) should be considered in patients with symptoms lasting ≥14 days and unidentified sources, and in those with a worsening clinical course unresponsive to management. Further work-up is required for traveler's diarrhea if there is fever or bloody stool. Evaluation for parasitic infection is recommended if diarrhea lasts >14 days. Reassessment of the patient's nutritional status, fluid and electrolyte balance, and optimal dose and duration of antimicrobial therapy is recommended in patients with persistent symptoms. Imaging (eg endoscopy or colonoscopy) may be indicated, and specialist consultation with a gastroenterologist may be beneficial in the evaluation of the patient's worsening status.

  
The MIMS logo.
  • Drugs
  • Find Drugs
  • Pill Identifier
  • Find Drug Company
  • MIMS Abbreviation Index
  • Diseases
  • Search Disease Information
  • Editorial Advisory Board
  • Medical News & Updates
  • Latest News & Updates
  • More Services
  • Education
  • Subscribe
  • About
  • MIMS Corporate
  • Terms of Use
  • Privacy Policy
  • Feedback
Connect with MIMS
A social media brand icon.A social media brand icon.
TUV Nord ISO 9001 certification logo
MIMS Specialty release/v3.16.0_3176.1
Copyright © 2026 MIMS Pte Ltd. All rights reserved. UAT
MIMS Logo

Sign up for Free to continue reading

Already a member?

Sign up for Free to continue reading

Already a member?

Sign up for Free to continue reading

Already a member?
Something went wrong.